33 related articles for article (PubMed ID: 22574)
1. Dialysis Procedures Alter Metabolic Conditions.
Stegmayr B
Nutrients; 2017 May; 9(6):. PubMed ID: 28554992
[TBL] [Abstract][Full Text] [Related]
2. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
[TBL] [Abstract][Full Text] [Related]
3. Uremic toxins and lipases in haemodialysis: a process of repeated metabolic starvation.
Stegmayr B
Toxins (Basel); 2014 Apr; 6(5):1505-11. PubMed ID: 24784324
[TBL] [Abstract][Full Text] [Related]
4. Unfractionated heparin for hemodialysis: still the best option.
Cronin RE; Reilly RF
Semin Dial; 2010; 23(5):510-5. PubMed ID: 21039876
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucose-containing peritoneal-dialysis solutions on rates of lipogenesis in vivo in the liver, brown and white adipose tissue of chronic uraemic rats.
Klim RA; Williamson DH
Biochem J; 1983 Aug; 214(2):459-64. PubMed ID: 6351852
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance in uremia. Characterization of lipid metabolism in freshly isolated and primary cultures of hepatocytes from chronic uremic rats.
Caro JF; Lanza-Jacoby S
J Clin Invest; 1983 Sep; 72(3):882-92. PubMed ID: 6350367
[TBL] [Abstract][Full Text] [Related]
7. [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].
Hörl WH; Hörl M; Heidland A
Klin Wochenschr; 1982 Apr; 60(7):327-36. PubMed ID: 6122754
[TBL] [Abstract][Full Text] [Related]
8. Calcium/calmodulin-mediated action of calcitonin on lipid metabolism in rats.
Nishizawa Y; Okui Y; Inaba M; Okuno S; Yukioka K; Miki T; Watanabe Y; Morii H
J Clin Invest; 1988 Oct; 82(4):1165-72. PubMed ID: 2844851
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein lipase disturbances induced by uremia and hemodialysis.
Stegmayr B; Olivecrona T; Olivecrona G
Semin Dial; 2009; 22(4):442-4. PubMed ID: 19708998
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein metabolism in normal and uremic patients.
Goldberg IJ
Am J Kidney Dis; 1993 Jan; 21(1):87-90. PubMed ID: 8418633
[TBL] [Abstract][Full Text] [Related]
11. Hyperlipidemia in renal failure: studies of plasma lipoproteins, hepatic triglyceride production, and tissue lipoprotein lipase in a chronically uremic rat moedl.
Bagdade JD; Yee E; Wilson DE; Shafrir
J Lab Clin Med; 1978 Jan; 91(1):176-86. PubMed ID: 22574
[TBL] [Abstract][Full Text] [Related]
12. Is the glucocorticoid-induced hypertriglyceridemia in uremic rats caused by decreased tissue lipoprotein lipase activity?
Tan MH
Horm Metab Res; 1985 Nov; 17(11):580-2. PubMed ID: 4077022
[TBL] [Abstract][Full Text] [Related]
13. [Pathomechanism of hyperlipoproteinemia in chronic renal failure].
Rutkowski B; Łososowska R; Król E; Kisielnicka E; Zdrojewski Z; Szołkiewicz M; Niewegłowski T; Chmielewski M; Sucajtys E; Swierczyński J; Korczyńska J; Stelmańska E; Goyke E; Bogusławski W
Pol Merkur Lekarski; 2003 Oct; 15(88):322-3; discussion 323-5. PubMed ID: 14974358
[TBL] [Abstract][Full Text] [Related]
14. The role of lipogenesis in the development of uremic hyperlipidemia.
Rutkowski B; Szolkiewicz M; Korczynska J; Sucajtys E; Stelmanska E; Nieweglowski T; Swierczynski J
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S84-8. PubMed ID: 12612960
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
Vaziri ND; Kim CH; Dang B; Zhan CD; Liang K
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F90-4. PubMed ID: 15010358
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
